Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2002
CD28 plays a critical role in the segregation of PKC theta within the immunologic synapse
Jianyong Huang, Pei-Fen Lo, Tomasz Zal, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 5, 2011
Cutting edge: TIGIT has T cell-intrinsic inhibitory functions
Nicole Joller, Jason P Hafler, Boel Brynedal, et al.
Journal of Shoulder and Elbow Surgery
|
March 10, 2009
Biomechanical analysis of bursal-sided partial thickness rotator cuff tears
Scott Yang, Hyung-Soon Park, Steven Flores, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 31, 2011
A role for IL-27 in limiting T regulatory cell populations
Elia D Tait Wojno, Nancy Hosken, Jason S Stumhofer, et al.
Cancer Cell
|
January 7, 2004
Requirement for cyclin D3 in lymphocyte development and T cell leukemias
Ewa Sicinska, Iannis Aifantis, Laurent Le Cam, et al.
The Journal of Experimental Medicine
|
June 17, 2009
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
Cameron S Brandt, Myriam Baratin, Eugene C Yi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 2, 2023
Non-Redundant Roles of T Cell Costimulation Pathways in Inflammatory Arthritis Revealed by Dual Blockade of ICOS and CD28 with Acazicolcept (ALPN-101)
Stacey R Dillon, Lawrence S Evans, Katherine E Lewis, et al.
Frontiers in Immunology
|
February 11, 2020
Novel Immunomodulatory Proteins Generated via Directed Evolution of Variant IgSF Domains
Steven D Levin, Lawrence S Evans, Susan Bort, et al.
Nature Immunology
|
November 9, 2010
A role for IL-27p28 as an antagonist of gp130-mediated signaling
Jason S Stumhofer, Elia D Tait, William J Quinn, et al.
Nature Communications
|
April 5, 2022
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity
Mark F Maurer, Katherine E Lewis, Joseph L Kuijper, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2002
CD28 plays a critical role in the segregation of PKC theta within the immunologic synapse
Jianyong Huang, Pei-Fen Lo, Tomasz Zal, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 5, 2011
Cutting edge: TIGIT has T cell-intrinsic inhibitory functions
Nicole Joller, Jason P Hafler, Boel Brynedal, et al.
Journal of Shoulder and Elbow Surgery
|
March 10, 2009
Biomechanical analysis of bursal-sided partial thickness rotator cuff tears
Scott Yang, Hyung-Soon Park, Steven Flores, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 31, 2011
A role for IL-27 in limiting T regulatory cell populations
Elia D Tait Wojno, Nancy Hosken, Jason S Stumhofer, et al.
Cancer Cell
|
January 7, 2004
Requirement for cyclin D3 in lymphocyte development and T cell leukemias
Ewa Sicinska, Iannis Aifantis, Laurent Le Cam, et al.
The Journal of Experimental Medicine
|
June 17, 2009
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
Cameron S Brandt, Myriam Baratin, Eugene C Yi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 2, 2023
Non-Redundant Roles of T Cell Costimulation Pathways in Inflammatory Arthritis Revealed by Dual Blockade of ICOS and CD28 with Acazicolcept (ALPN-101)
Stacey R Dillon, Lawrence S Evans, Katherine E Lewis, et al.
Frontiers in Immunology
|
February 11, 2020
Novel Immunomodulatory Proteins Generated via Directed Evolution of Variant IgSF Domains
Steven D Levin, Lawrence S Evans, Susan Bort, et al.
Nature Immunology
|
November 9, 2010
A role for IL-27p28 as an antagonist of gp130-mediated signaling
Jason S Stumhofer, Elia D Tait, William J Quinn, et al.
Nature Communications
|
April 5, 2022
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity
Mark F Maurer, Katherine E Lewis, Joseph L Kuijper, et al.
Page
of 3